NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE    See Our Statement on Inclusive Care

Revised DAA Class Labeling Re: Risk of HBV Reactivation (2/14/17)

https://content.govdelivery.com/accounts/USFDA/bulletins/18741e2

What can I help you find in the guidelines?